| Nov 16 |
Denali Has A Neurodegenerative Edge Despite Market Skepticism
|
| Nov 15 |
We're Hopeful That Denali Therapeutics (NASDAQ:DNLI) Will Use Its Cash Wisely
|
| Nov 8 |
Denali Q3 Earnings Miss Estimates, Pipeline Progress Encouraging
|
| Nov 7 |
Denali Therapeutics GAAP EPS of -$0.63
|
| Nov 6 |
Denali Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights
|
| Oct 30 |
Analysts Estimate Arcus Biosciences, Inc. (RCUS) to Report a Decline in Earnings: What to Look Out for
|
| Oct 29 |
Denali Therapeutics Inc. (DNLI) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
|
| Oct 13 |
Denali Therapeutics Inc. (DNLI): Jeff Bezos Is Buying This Stock Now
|
| Oct 11 |
Sanofi, Denali face another mid-stage setback for neurology therapy
|
| Oct 7 |
Strength Seen in Voyager Therapeutics (VYGR): Can Its 17.5% Jump Turn into More Strength?
|
